Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals

Scholarly Works

• Huang, Q.; Wu, W.; Liu, Y.; Li, W.; Chen, X.; Yu, S.; Gong, G.; Shu, H. Research Progress on Nasal Delivery of siRNA Nanocarrier Systems for the Treatment of Neurodegenerative Diseases. Pharmaceutics 2025, 17, 1407. doi:10.3390/pharmaceutics17111407
• Naki, T.; Peter, S.; Alven, S. Polymeric Nanocarrier-Based Drug Formulations for Enhancing Nose-to-Brain Delivery. Pharmaceutics 2025, 17, 1242. doi:10.3390/pharmaceutics17101242
• Cueto-Ureña, C.; Ramírez-Expósito, M. J.; Carrera-González, M. P.; Martínez-Martos, J. M. Hydroxytyrosol and Brain Tumors: Mechanisms of Action and Therapeutic Potential. Current issues in molecular biology 2025, 47, 667. doi:10.3390/cimb47080667
• Peres, C.; Meirinho, S.; Ferreira da Silva, S.; Maocha, I.; Chiangalala, A.; Alves Ferreira, S.; Rodrigues, M.; Zhang, S.; Kumar, N.; Sitruk-Ware, R.; Caetano Oliveira, R.; Gaspar, C.; Palmeira-de-Oliveira, A.; Palmeira-de-Oliveira, R.; Alves, G.; Baltazar, G.; Santos, A. O. Optimized intranasal delivery of segesterone acetate progestin to the brain using nanoemulsions and microemulsions. Drug delivery and translational research 2025. doi:10.1007/s13346-025-01897-7
• Singh, M.; Kumar, S.; Vinayagam, R.; Samivel, R. Thermosensitive Mucoadhesive Intranasal In Situ Gel of Risperidone for Nose-to-Brain Targeting: Physiochemical and Pharmacokinetics Study. Pharmaceuticals (Basel, Switzerland) 2025, 18, 871. doi:10.3390/ph18060871
• Wu, H.; Li, C.; Yuan, H.; Zhao, J.; Li, S. Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration. International journal of nanomedicine 2025, 20, 6463–6487. doi:10.2147/ijn.s520768
• Watanabe, S.; Ueda, M.; Asayama, S. Inhibition of Aβ Aggregation by Cholesterol-End-Modified PEG Vesicles and Micelles. Pharmaceutics 2024, 17, 1. doi:10.3390/pharmaceutics17010001

Explore citations to this article at